申请人:Schering Corporation
公开号:US04292323A1
公开(公告)日:1981-09-29
This application relates to phenyl-substituted 1,2,3,4-tetrahydrocarbazoles and to their use as anti-depressant agents useful in the treatment of mental depression of either endogenous or reactive nature.
该应用涉及苯基取代的1,2,3,4-四氢咔唑,并将其用作抗抑郁剂,可用于治疗内源性或反应性精神抑郁症。